Objectives : To evaluate the effect of repeated vaginal administration of small doses of misoproslol for termination of pregnancy in cases of second and third trimester pregnancies complicated with intra-ulcrinc fetal death (IUFD). Design: A prospective Clinical Trial. Setting : Tanta University Hospitals . Patients : The study was carried out on 40 women during the second and third trimesters of pregnancy complicated with IUFD. Intervention: All the patients were subjected to history taking, physical examination, Bishop Scoring. Application of 25 ug misoprostol (Vagiprost® tablet) in the posterior fornix of the vagina, which will be repeated every 4 hours over 24 hours. Outcome measures: The primary outcome measure was the success rate, the secondary outcome measure was the induction to delivery time, and third outcome measure was the number of patients requiring augmentation with oxytocin and all complications were recorded. Results: The mean value of induction contraction interval in cases of 2nd trimester IUFD (15.3±5.37 hours) was significantly higher than that in cases of 3rd trimester IUFD (8.95+2.625 hours). There was a significant negative correlation between gestalional age and induction contraction interval as well as induction delivery interval. The success rate was 90% and 45% in the third and second trimesters respectivley. Ninety percent of 2nd trimester cases and 55% of 3rd trimester cases required oxytocin augmentation. The mean values of total required dose of misoprostol required for induction wer 120+.28.79 u.g and 166.3±7.5 fig for the third and second trimesters respectively. Conclusion: Vagiprost is a very effective drug for termination of pregnancy in cases of IUFD, its effects increase in direct proportion with parity and duration of pregnancy. Key words: Misoprostol; induction of laboru; intrauterinc fetal death.
Intrauterine foetal death (IUFD) is a common obstetric complication that can lead to serious maternal complications if left to resolve spontaneously* 1^.
The management of IUFD poses a dilemma.
Although a significant number of these patients will spontaneously go into labour within several weeks many do not. Moreove, after the diagnosis, the social pressures and emotional aspects of delivery are usually considerable, and the medical consequences of postponing delivery can be significant. Unfortunately, the drug most commonly used for induction of labour, oxytocin, is frequently ineffective in stimulating the uterus, especially the preterm one. Within the past two decades, prostaglandins (PGs) have provided an alternative method for induction of labour in women with IUFD (2) .
Misoprostol (PGE1 analogue) has been widely used for cervical ripening and labour induction in various pregnancy conditions, at different gcstational ages and using different routes of administration and dose regimens (3 Inclusion criteria :
• IUFD with gestational age > 13 weeks.
• Absent spontaneous laabour pain.
• Bishop cervical score < 5.
Exclusion criteria :
• Cases with general contraindications to PGs including: epilepsy, glaucoma, cardiac disease, bronchial asthma, renal or hepatic dysfunction.
diabetes and history of hypersensitivity to PGs.
Cases with local contraindications to PGs including:
Grand multiparas, fetal macrosomia, multiple pregnancies, abnormal presentation, previous uterine scar, Bishop score > 5, PROM, Placenta praevia, Contracted pelvis and Ccphalo-pelvic disproportion.
METHODS
• All cases were subjected to :-
• History taking, clinical examination & ultrasound examination.
• Counseling the patient & obtaining written consent.
• Determination of Bishop Score before application of PG.
• Application of 25ug misoprostol (Vagiprost® tablet)
in the posterior lb mix of the vagina, which will be repeated every 4 hours over 24 hours. The tablet was covered with K-Y gel before insertion.
• Observation of patients over 24 hours, after • Recording the total dose of misoprostol administered 6 the need for surgical interference to remove the retained placenta.
• Failure of delivery within 24 hours is considered "failed trial", but it's not an indication to stop the trial i.e. the trial will be completed till termination.
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Observation of patients for 24 hours after delivery.
Any complications during induction and 24 hours after delivery should be observed & reported.
RESULTS
The mean gestational age (GA) in primiparae (PI) and second para (P2) was 25.Stl.378 weeks, which was significantly higher than that in nullipara (PO) which was 22.67±2.50 weeks. The mean GA in third para (P3) and fourth para (P4) was 26.375±0.74 weeks.
This value was significantly higher than that in PO. There was a significant negative correlation between parity and induction contraction interval. Also, there was a significant negative correlation between parity and induction delivery interval. Also, there was a highly significant negative correlation between parity and total needed dose of misoprostol. There is a highly significant negative correlation between gestational age and induction contraction interval. Also, there was a highly significant negative correlation between gestational age and induction delivery interval. Also, there was a highly significant negative correlation between gestational age and total needed dose of misoprostol. From table (IX) it is clear that there was no significant difference between the mean value of induction contraction interval in P1&P2 and that in P0 (P>0.05). The mean value of induction contraction interval in P3&P4 was significanlly lower than that in P0 (P<0.05). The mean of induction contraciton interval in P3&P4 was significantly lower than that inPl&P2(P<0.05). Ftom table (X) we see that the mean value of induction delivery interval in PI & P2 was significantJy lower thant that in P0 (P<0.05). also the mean value of induction delivery interval in P3*P4 was significantJy lower than that in P0 (P<0,05). The mean induction delivery interval in P3&4 was significantly lower than that in P1&P2 (P<0.05). From table (XI) it clear that the mean value of total needed dose of misoprostol in P1&2 was significantly lower than that in P0, the mean value of total needed dose of misoprostol in P3&P4 was significantly lower thant that in P0 and there was no significant difference between the mean value of total needed dose of misoprostol in P1&P2. Table ( XII) shows that the mean value of induction contraction interval in cases of 2nd trimester IUFD was significfinlly higher than that incases of 3rd trimester IUFD (P<0.01). The mean of induction delivery interval in cases of 2nd trimester IUFD was also, significantly higher than that in cases of 3rd trimester IUFD. The mean value of total required doses of misoprostol in cases of 2nd trimester IUFD was significantly higher than that in cases of 3rd trimester IUFD. From table (IVX) it is clear that: the need for surgical interference because of retained placenta was significantly higher in 2nd trimester IUFD than that in 3rd trimester women with IUFD. ' . These data support the rationale of misoprostol application at 4-h used in our study.
In the current investigation, we found a significant negative correlation between parity and induction contraction interval. There was a significant negative correlation between parity and induction delivery interval. Also, there was a highly significant negative correlation between parity and total needed dose of misoprostol.
on the contrary to our above mentioned results, Auxiliadora de Aquino and Cccatlr 3^ found no significant differences between the groups concerning conditions for labor induction, age, parity, race, marital status, family income, initial Bishop Index and number of prenatal vistis.
We found highly significant negative correlation between gestational age and induction contraction interval; between gestational age and induction delivery interval and between gestational age and total needed dose of misoprostol. Nakintu (14) studied 120 The side effects were mainly nausea, vomiting, shivering and pyrexia especially with misoprostol but these were transient. There were no cases of ruptured uterus in both groups. Retained placenta occurred in only 3.3% of the patients in the misoprostol group.
The present investigation shows that the mean value of induction contraction interval in cases of 2nd and 3rd trimesters IUFD in primipara and second para was significantly lower than that in nulliparae. Similarly, the mean of induction contraction interval in third and fourth para was significantly lower than that in nulliparae. There was no significant difference between the mean of induction contraction interval in primipara, second para and that in third and fourh para. We found also, that the mean value of induction contraction interval in cases of 2nd trimester IUFD (15.3±5.37 hours) was significantly higher than that in cases of 3rd trimester IUFD (8.95+2.625 horus).
This agrees with the reports of Nakintu *■ ' who stated that the earlier the gestational age, the longer was the induction to delivery interval.
Bugalho and his colleagues ^1 5^ found that the average induction-to-delivery interval was 14. The existing study revealed that the mean values of total required dose of misoprostol in cases of 2nd and 3rd trimesters IUFD in nullipara was significantly higher than that required in parous women. Increased parity had no significant effect on the mean value of the required dose. The average of total required doses of misoprostol in cases of 2nd trimester IUFD (166.3±57.5 jig) was significantly higher than that in cases of 3rd trimester IUFD (120±28.79 Hg).
We found that the need for oxytocin augmentation was significantly higher in cases of 2nd trimester IUFD (90% of cases ) than that in 3rd trimester IUFD (55% of cases). Nycndc ^ ' found that 20% of his cases required oxytocin augmentation to complete the induction of labour.
The need for surgical interference for retained placenta was significantly higher in cases of 2nd
trimester IUFD (30% of cases).
The success rate in cases of 2nd trimester IUFD was 45% (wc considered successful when induction delivery interval was less than 24 hours). Regarding of cases of the third trimester IUFD, the success rale was 90%. This rcsutl agrees with that of many other authors < 18 "
19
) who reported that with misoprostol administration, the vast majority of women with IUFD will deliver gvaginally within 24-hours. Nakintu *' 4 ) studied 120 women at 18 to 40 weeks of pregnancy complicated with IUFD. He found that the success rate of induction within 48 hours of induction was 100<# which is identical to our results.
Last but not least, wc conclude that Vagiprosl® is a very effective drug for termination of pregnancy in cases of IUFD; its effects increase in direct proportion with parity and duration of pregnancy.
